We are live on ! Find out more
TLP

Tri Locum Partners Portfolio holdings

AUM $713M
1-Year Est. Return 68.92%
This Fund
S&P 500
This Quarter Est. Return
-0.92%
1 Year Est. Return
+68.92%
3 Year Est. Return
+377.81%
5 Year Est. Return
+1,289.15%
10 Year Est. Return
–
AUM
$313M
AUM Growth
+$43.7M
Cap. Flow
+$70.4M
Cap. Flow %
22.5%
Top 10 Hldgs %
58.61%
Holding
92
New
33
Increased
17
Reduced
11
Closed
31

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$26.8M
2
DXCM icon
DexCom
DXCM
+$24.3M
3
ABBV icon
AbbVie
ABBV
+$21.2M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$20.1M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$14.2M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$25.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$21.1M
3
MDT icon
Medtronic
MDT
+$14.2M
4
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$9.82M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$8.66M

Sector Composition

Rank Sector Weight
1 Healthcare 92.58%
2 Industrials 0.23%
3 Financials 0.16%
4 Technology 0.14%
5 Energy 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GKOS icon
26
Glaukos
GKOS
$10.1B
$4.23M 1.35%
+56,230
New +$4.2M
ETNB
27
DELISTED
89bio
ETNB
$3.85M 1.23%
249,571
+83,674
+50% +$1.4M
ALPN
28
DELISTED
Alpine Immune Sciences Inc
ALPN
$3.6M 1.15%
314,029
-17,963
-5% -$221K
IMTX icon
29
Immatics
IMTX
$1.28B
$3.53M 1.13%
304,974
+222,922
+272% +$2.66M
MLTX icon
30
MoonLake Immunotherapeutics
MLTX
$1.53B
$3.04M 0.97%
+53,300
New +$2.94M
AZN icon
31
AstraZeneca
AZN
$241B
$3M 0.96%
+22,117
New +$3.02M
ISRG icon
32
Intuitive Surgical
ISRG
$130B
$2.44M 0.78%
+8,353
New +$2.61M
TVTX icon
33
Travere Therapeutics
TVTX
$5.21B
$2.25M 0.72%
+251,702
New +$3.55M
SLRN
34
DELISTED
ACELYRIN
SLRN
$1.58M 0.51%
+155,573
New +$3.3M
KVUE icon
35
CALL
Kenvue
KVUE
$37.5B
$1.1M 0.35%
+55,000
New +$1.27M
MORF
36
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$839K 0.27%
+36,606
New +$1.92M
GERN icon
37
Geron
GERN
$860M
$808K 0.26%
+381,081
New +$1.03M
VERA icon
38
Vera Therapeutics
VERA
$2.15B
$596K 0.19%
43,438
-65,490
-60% -$1.12M
HIG icon
39
Hartford Financial Services
HIG
$38.9B
$248K 0.08%
3,500
+466
+15% +$33.8K
ELV icon
40
Elevance Health
ELV
$82B
$247K 0.08%
+568
New +$258K
SDGR icon
41
Schrodinger
SDGR
$1.17B
$235K 0.08%
8,316
-8,146
-49% -$328K
FEMY icon
42
Femasys
FEMY
$9.21M
$228K 0.07%
3,830
-1,755
-31% -$18.3K
UPS icon
43
United Parcel Service
UPS
$92.7B
$222K 0.07%
+1,423
New +$246K
YUM icon
44
Yum! Brands
YUM
$40.3B
$219K 0.07%
+1,751
New +$230K
APH icon
45
Amphenol
APH
$211B
$217K 0.07%
5,164
-94
-2% -$4.04K
ITW icon
46
Illinois Tool Works
ITW
$84.9B
$215K 0.07%
+932
New +$227K
TEL icon
47
TE Connectivity
TEL
$62.9B
$214K 0.07%
+1,732
New +$232K
HSY icon
48
Hershey
HSY
$36B
$204K 0.07%
+1,020
New +$228K
FAST icon
49
Fastenal
FAST
$57B
$200K 0.06%
+7,328
New +$208K
DOC icon
50
Healthpeak Properties
DOC
$14.9B
$188K 0.06%
+10,215
New +$210K
1
2
3 4

Similar funds

DCM
Defilade Capital Management Emeryville, California $712M AUM
AMPWP
Alvarez & Marsal Private Wealth Partners West Palm Beach, Florida $712M AUM
DCM
Dimension Capital Management Coral Gables, Florida $713M AUM 18.57% 1-Year Est. Return
IWP
Insight Wealth Partners Plano, Texas $713M AUM 16.55% 1-Year Est. Return
PCS
Personal CFO Solutions Chester, New Jersey $712M AUM 25.3% 1-Year Est. Return
ACGDR
Atmos Capital Gestao de Recursos Leblon - Rio De Janeiro, Brazil $714M AUM 35.97% 1-Year Est. Return
GEA
Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return
ECM
EagleClaw Capital Management Boston, Massachusetts $714M AUM 24.24% 1-Year Est. Return

Tri Locum Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Tri Locum Partners held 92 positions worth $313M, up 16% from $269M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Tri Locum Partners deployed $70.4M of net new capital in Q3 2023, opening 33 new positions and adding to 17 existing holdings. Its largest new stake was Amgen: 107,480 shares worth $28.9M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 99% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was West Pharmaceutical, an estimated $7M trimmed.

  • Tri Locum Partners's largest Q3 2023 buy was Amgen: 107,480 shares worth $28.9M.
  • Tri Locum Partners added most to DexCom in Q3 2023, an estimated $24.3M increase.
  • Tri Locum Partners's biggest Q3 2023 reduction was West Pharmaceutical, cutting an estimated $7M.
  • Tri Locum Partners fully exited Eli Lilly in Q3 2023, selling an estimated $25.5M.
  • Tri Locum Partners's ten largest holdings make up 59% of its $313M portfolio in Q3 2023.
  • Tri Locum Partners opened 33 new positions and closed 31 in Q3 2023.
  • Tri Locum Partners's portfolio value rose 16% quarter-over-quarter to $313M.

Based on Tri Locum Partners's 13F filing for Q3 2023, filed 14 Nov 2023.